StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Pfizer (PFE) PT Raised to $45 at Morgan Stanley
August 23, 2018 6:52 AM
Morgan Stanley analyst David Risinger ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Next Articles
Pfizer (PFE) Reports Tafamidis Phase 3 Transthyretin Amyloid Cardiomyopathy (ATTR-ACT) Study Results at ESC Congress 2018
August 27, 2018 5:40 AM